AVN 12% Strides Linked TO Apple, Inc.

AVANIR Pharmaceuticals (AMEX: AVN) announces the following Webcast: What: AVANIR Pharmaceuticals Second Quarter 2005 Conference Call Webcast When: May 16, 2005 @ 04:30 PM Eastern Where: http://www.vcall.com/EventPage.asp?ID=91764 How: Live over the Internet -- Simply log on to the web at the address above. Contact: Patrice A Saxon, (858)622-5202 or psaxon@avanir.com If you are unable to participate during the live webcast, the call will be available for replay at http://www.vcall.com/ClientPage.asp?ID=91764 or http://www.vcall.com/ AVANIR Pharmaceuticals is a drug discovery and development company focused on developing and commercializing novel therapeutic products for the treatment of chronic diseases. AVANIR's product candidates address therapeutic markets that include central nervous system and cardiovascular disorders, inflammation, and infectious disease. The Company's first commercialized product, Abreva(R), is marketed in North America by GlaxoSmithKline Consumer Healthcare and is the leading over-the-counter product for the treatment of cold sores. Further information about AVANIR can be found at www.avanir.com.